Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    September 2017
  1. CHAYAMA K, Suzuki F, Karino Y, Kawakami Y, et al
    Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
    J Gastroenterol. 2017 Sep 25. doi: 10.1007/s00535-017-1391.
    PubMed     Text format     Abstract available


    August 2017
  2. KOBAYASHI K, Maruyama H, Kiyono S, Ogasawara S, et al
    Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis.
    J Gastroenterol. 2017 Aug 18. doi: 10.1007/s00535-017-1378.
    PubMed     Text format     Abstract available


    July 2017
  3. KITAJIMA Y, Takahashi H, Akiyama T, Murayama K, et al
    Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
    J Gastroenterol. 2017 Jul 24. doi: 10.1007/s00535-017-1370.
    PubMed     Text format     Abstract available


    February 2017
  4. SETO WK, Yuen MF
    Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    J Gastroenterol. 2017;52:164-174.
    PubMed     Text format     Abstract available


    December 2016
  5. WANG W, Pan Q, Fuhler GM, Smits R, et al
    Action and function of Wnt/beta-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.
    J Gastroenterol. 2016 Dec 29. doi: 10.1007/s00535-016-1299.
    PubMed     Text format     Abstract available


  6. OGAWA E, Furusyo N, Nomura H, Dohmen K, et al
    NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  7. SETOYAMA H, Tanaka M, Nagumo K, Naoe H, et al
    Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  8. KUMADA H, Suzuki Y, Karino Y, Chayama K, et al
    The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  9. TERAI S, Tsuchiya A
    Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  10. KIYONO S, Maruyama H, Kondo T, Sekimoto T, et al
    Erratum to: Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format    


  11. TOYOTA J, Karino Y, Suzuki F, Ikeda F, et al
    Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  12. SAKAIDA I, Terai S, Nakajima K, Shibasaki Y, et al
    Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  13. YAMADA N, Sanada Y, Tashiro M, Hirata Y, et al
    Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  14. FUKUI H, Saito H, Ueno Y, Uto H, et al
    Evidence-based clinical practice guidelines for liver cirrhosis 2015.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  15. TANAKA A, Takikawa H, Mochida S, Koike K, et al
    Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".
    J Gastroenterol. 2016.
    PubMed     Text format    


    April 2016
  16. SUGIYAMA A, Kanno K, Nishimichi N, Ohta S, et al
    Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via alpha integrin interaction.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  17. KIYONO S, Maruyama H, Kondo T, Sekimoto T, et al
    Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  18. NAKANISHI H, Kurosaki M, Hosokawa T, Takahashi Y, et al
    Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  19. YANG SL, Liu LP, Sun YF, Yang XR, et al
    Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  20. TADA T, Kumada T, Toyoda H, Kiriyama S, et al
    Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  21. DEGIORGIO D, Crosignani A, Colombo C, Bordo D, et al
    ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  22. NAMISAKI T, Noguchi R, Moriya K, Kitade M, et al
    Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  23. FUJIYOSHI M, Kuno A, Gotoh M, Fukai M, et al
    Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  24. SAKAI Y, Iwata Y, Enomoto H, Saito M, et al
    Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.
    J Gastroenterol. 2015;50:109-18.
    PubMed     Text format     Abstract available


  25. TOSHIMA T, Shirabe K, Ikegami T, Yoshizumi T, et al
    A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
    J Gastroenterol. 2015;50:76-84.
    PubMed     Text format     Abstract available


    December 2014
  26. AOKI Y, Sugiyama M, Murata K, Yoshio S, et al
    Association of serum IFN-lambda with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    November 2014
  27. YASUI K, Kawaguchi T, Shima T, Mitsuyoshi H, et al
    Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    August 2014
  28. HUANG CF, Sun CC, Zhao F, Zhang YD, et al
    miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    June 2014
  29. TATEISHI R, Okanoue T, Fujiwara N, Okita K, et al
    Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    May 2014
  30. IRITANI S, Imai K, Takai K, Hanai T, et al
    Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    December 2013
  31. TAMAKI N, Kurosaki M, Matsuda S, Muraoka M, et al
    Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


  32. YAMASHITA N, Ohho A, Yamasaki A, Kurokawa M, et al
    Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes.
    J Gastroenterol. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: